Clinical Trial Update: Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of low-dose-rate brachytherapy with immune checkpoint inhibitors in cancer; the study includes cutaneous malig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Malignant Melanoma
• Renal Cell Carcinoma
• Urothelial Carcinoma of the Renal Pelvis

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Cutaneous Malignant Melanoma, Renal Cell Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING